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Introduction 
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Streptococcus pyogenes is one of the pathogens which is common and 
can cause a wide range of diseases with varied differences in the severity. The 
frequent manifestation is pharyngitis.
1
 S.pyogenes is one the leading cause of 
acute pharyngitis caused by bacteria resulting in about 15-30% of cases in 
children and 5-10% in adults
2
. S.pyogenes is capable of a wide range of 
infections which include suppurative and non-suppurative infections. The 
suppurative infections being streptococcal sore throat, pharyngitis, impetigo, 
scarlet fever, erysipelas, postpartum (puerperal) fever, necrotizing fasciitis, 
septicemia and toxic shock syndrome. 
The non-suppurative complications being acute rheumatic fever,gas 
gangrene and acute post-streptococcal glomerulonephritis.  During winter and 
spring, up to 20% of school-aged children who are asymptomatic  may be 
Group A Streptococcus carriers falling in the age group of 5-15 years. Cellulitis 
is caused by Staphylococcos aureus mostly apart from staphylococcus, 
Streptococci also play a role in cellulitis. Person to person transmission is 
mainly through respiratory droplets or by direct contact with the nasal secretion 
of infected person or throat or by contact with infected wound on the skin. A 
study conducted in USA showed the highest mortality of 3/100,000 population 
due to S.pyogenes infections this is relatively uncommon when compared to 
other infections
3
. 
It has been estimated that nearly seven sore throat episodes occur per 
child per year with 13.5% of these being caused mainly by the Group A 
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Streptococcus (GAS)
2
. The detailed information on the occurrence of invasive 
streptococcal infections in India is limited. There are at least 517,000 deaths 
globally every year due to severe S.pyogenes infections and rheumatic fever 
disease are the major causes of 233,000 deaths. 1,800 invasive S.pyogenes 
disease-related deaths are reported in the USA per year, death caused by 
necrotizing fasciitis is about 30% of patients and streptococcal toxic shock 
syndrome has a mortality rate of 30-70%. Worldwide, there are estimated to be 
more than 600 million cases of GAS pharyngitis and more than 100 million 
cases of GAS pyoderma annually. Different clinical manifestations of this 
bacterium are more common in different parts of the world.
4
   
Even though S.pyogenes is susceptible to penicillin, the infections 
continues to be a major health problem in developing countries because the 
epidemiology of streptococci is being poorly investigated, however the 
available data indicates that these infections are of high public health 
importance.  Diseases caused by the Group A Streptococcus is a major problem 
in India and in some developing countries. Therefore, a continued study about 
these infections is imperative to monitor the epidemiological trends. 
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THROAT CARRIAGE OF STREPTOCOCCI  
About 5 to 15% of cases of pharyngitis in adults caused by S.pyogenes 
and in case children 20 to 30 percent between 5 to 15 years of age.  S.pyogenes 
is the most common cause of pharyngitis occurs among children between 5 and 
15 years of age.  
Untreated patients can develop purulent complications like otitis media, 
sinusitis, peritonsillar, oropharyngeal abscesses & cervical lymphadenitis. The 
importance of respiratory tract infection is related to its acute morbidity and its 
non suppurative sequelae i.e acute rheumatic fever and acute 
glomerulonephritis. 
 One of the leading causes of acquired heart disease in countries like 
Africa, India is Rheumatic fever, but it is uncommon in developed countries. 
Transmission rates of group A streptococcal infection is nearly 35% within a 
family or school if a patient is untreated. The carrier rate is different in 
developed and developing countries. It is usually spread directly by person to 
person contact through respiratory droplets or saliva. Respiratory droplets are 
the common mechanism of spread because this organism which is primarily 
located in the throat. 
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The symptoms of pharyngitis caused by Streptococcus pyogenes are 
sudden in onset. 
The symptoms are 
1. Throat pain 
2. Fever and body pain 
3. Headache  
4. Nausea, vomiting 
5. Abdominal pain mainly in younger children. 
Scarlet fever may be associated with Streptococcal phryngitis which 
produces reddish popular lesions in the skin which spare the face and 
desquamate while recovery.  
The diagnosis of streptococcal pharyngitis based on clinical grounds is 
unreliable. Symptoms and signs are variable and the severity of illness may 
vary from mild throat discomfort to classic exudative pharyngitis with high 
fever & prostration. The diagnosis is further complicated because the infection 
caused by many other agents may mimic the clinical symptoms of 
streptococcal pharyngitis. 
If timely intervention is done by the physician for diagnosis of 
streptococcal pharyngitis by conventional methods, then the treatment can be 
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possible with the proper use of appropriate antibiotics and can prevent the long 
term non suppurative complication includes glomerulonephritis & rheumatic 
fever which has a prevalence of 4 to 6 per 1000 children per annum in the 
developing countries. 
This study is aimed to find the epidemiology of Group A streptococcal 
infections in and around Coimbatore and also to study the prevalence of throat 
carriage of Streptococcus pyogenes among school children. 
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Review of Literature 
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Human pathogenic Beta Hemolytic Streptococci 
Streptococci come under the family Streptococcacae. They are Gram-
positive aerobic and facultative anaerobic organisms that occur in chains or 
pairs. Theodor Billroth in 1874 proposed the name Streptococcus and was the 
first to identify these organisms in patients with skin infections In Greek, 
streptos means chain and kokhos means berry, which refers to the globular 
shaped structures, hence the name of the genus, Streptococcus following which 
the individual streptococcal species became named after the diseases they 
caused or sites of infection. The species pyogenes was coined by Friedrich 
Julius Rosenbach in 1884.
5
 
At the beginning of the 20th Century, the classification of streptococci 
was based on their differential capacity to induce hemolysis on blood agar 
following which a serological classification based on group specific 
polysaccharides was proposed by Rebecca Lancefield during the 1930s. Further 
subdivision of group A streptococci by her, was based on the M protein, which 
is found on the surface of the bacterial cell wall. It is a virulence factor and 
prevents phagocytosis. During the 1920s and 1930s, further researches 
contributed to the identification of the toxins (streptococcal pyrogenic 
exotoxins) produced by streptococci and their role in the pathogenesis of 
scarlet fever. 
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Streptococcus species and their Lancefield grouping 
 S. pyogenes comes under Lancefield group A and it causes human 
infections alone. 
 S. agalactae belongs to group B and it causes both human and 
bovine infections 
 S. dysgalactiae  Subsp. Equisimilis belong to various groups like 
A,C,G,L and it causes both animal and human infections. 
 S. equi  Subsp. Zooepidemicus comes under group C and it causes 
both animal and human infections 
 S. canis belongs to group G and it causes infections in dogs and 
human. 
 S. anginosus (group) belongs to Lancefield group A,C,F,G and it 
causes human infections 
 S. constellatus , Subsp. Pharyngis come under group C and it causes 
infections in human.
5
 
A study from USA reported about the re emergence of GAS infections 
mainly rheumatic fever which is one of the non suppurative complication of S. 
pyogenes. M1 and M3 sero types plays major role in the invasive infections of 
S.pyogenes. 
10 
 
Streptococcal toxic shock-like syndrome, a newer disease caused by 
Group A Streptococci was identified in 1980 by USA. The reports of which 
were reviewed by a CDC working group and a case definition for Streptococcal 
toxic shock-like syndrome was established. Necrotizing fasciitis, pneumonia, 
puerperal sepsis, septic arthritis, STSS and non-focal bacteraemia are some of 
the invasive diseases caused by Streptococcus pyogenes.
6 
Group A streptococci (GAS), Streptococcus pyogenes: 
Carriage: 
Streptococcus pyogenes produces human infections it does not cause any 
infection in animals. It can be carried asymptomatically on the superficial 
layers of the skin and the mucous membranes like, the oropharyngeal mucosa, 
the nasal mucosa, the perianal area and the genital tract. A pharyngeal carrier of 
GAS is defined as an asymptomatic individual with a positive throat culture, 
with no active immune or inflammatory response, or an asymptomatic child 
who after completing the antimicrobial treatment of GAS pharyngitis tests 
positive for GAS.
7-9 
Children in the age group of 5-15 years are considered to be the major 
reservoir of GAS and 15-25% or more of them are found to be pharyngeal 
carriers. The pharyngeal carrier rate in adults is found to be <5%, which when 
compared to children is very low. But the carrier state can vary with age, 
season and the geographical location. Carriers can either be a transient carrier 
11 
 
or a persistent carrier, and a new type of GAS can replace a carried strain. 
Persistent throat carriage may be due to the internalization of GAS into the 
epithelial cells, which protects the pathogen from the antimicrobial agents.
7
 
Transmission:  
The transmission of bacteria from carriers, especially pharyngeal 
carriers to other persons and the surroundings occur by  
 Direct contact with respiratory secretions 
 Aerosol spread by droplets 
 Disease spectrum
 
The mortality of invasive S. pyogenes infection is high, ranging between 
10% and 30%. 650,000 deaths per year have been estimated to be due to these 
infections. Streptococcus pyogenes causes a wide range of clinical infections 
including respiratory, cutaneous, skin, soft tissue and other systemic infections. 
Suppurative infections commonly associated with this organism are as follows: 
Non-focal bacteremia is a suppurative infection produced by S.pyogenes  
Impetigo, carditis, meningitis, cellulitis, erysipelas are the skin and soft tissue 
infections of S.pyogenes 
Epiglottitis, Pharyngitis, Empyema, Scarlet fever, Mastoiditis, 
Tonsillitis, Otitis and Pneumonia are the upper and lower respiratory tract 
12 
 
infections. Peritonitis, Appendicitis are abdominal infections caused by 
S.pyogenes Puerperal sepsis, Vaginitis are the pelvic infections 
Acute tonsillitis and acute pharyngitis are the 2 common infections 
produced by S.pyogenes. Certain strains of S.pyogenes express one or more 
pyrogenic exotoxins (A, B or C). Scarlet fever is caused by one such strain and 
is thus associated with toxin-mediated symptoms like rash, strawberry tongue, 
and skin desquamation. Before the advent of antimicrobials, Scarlet fever used 
to be fatal infection and caused epidemics with a high mortality. But in this 
modern era, with the availability of appropriate antimicrobials, it has now 
become less severe, that present as pharyngitis with skin rash. 
In addition to these infections, S. pyogenes can also cause various other 
localized infections, such as pneumonia, puerperal sepsis, meningitis, 
peritonitis and septic arthritis. Puerperal sepsis, a dreadful disease, also known 
as childbed fever, is an infection predominantly caused by GAS. In Europe it 
was most common cause of high mortality in young women during 18
th
 
century.  
Streptococcal toxic shock syndrome is the most fatal complication 
associated with S.pyogenes infection. It is also associated with highmortality
7
. 
STSS and scarlet fever comes under toxin-mediated diseases caused by S. 
pyogenes. 
13 
 
Non suppurative complications 
Infection with S.pyogenes also causes two potentially serious non 
suppurative complications which includes acute rheumatic fever and acute 
glomerulonephritis 
Acute rheumatic fever: 
Acute rheumatic fever (ARF) commonly occurs after two to three weeks 
following group A streptococcal pharyngitis which occurs most commonly in 
children. It has cardiac, rheumatologic and neurologic manifestations. Since 
many physicians from most developed countries have little or no practical 
experience with the diagnosis and management of ARF, its incidence has 
declined in these areas. But outbreaks occur occasionally in the United States 
and pose a threat to public health. 
Diagnosis is based on various clinical manifestations that develop as a 
result of group A streptococcal pharyngitis. The major clinical manifestations 
include subcutaneous nodules, migratory polyarthritis, erythema marginatum, 
carditis and chorea. If the pharyngeal infection is treated promptly, acute 
rheumatic fever can be completely prevented. Hence larger attention has been 
drawn towards preventive measures of this condition.  
14 
 
Acute glomerulonephritis: 
 Non-complement fixing antibodies to glomerular epithelial cell 
membrane antigens and those resembling membranous nephropathy are 
induced by glomerular epithelial cell membrane insertion of the C5b-9 
membrane attack complex of complement. The mechanisms of these effects at 
the cellular level are however unclear but may involve the activation of 
glomerular epithelial cell and the release of local mediators like proteases or 
oxidants, or detachment of glomerular epithelial cell from underlying basement 
membrane.  
The circulating inflammatory cells like neutrophils, macrophages, 
platelets and/or the resident glomerular cells (mesangial cells) mediate 
inflammatory types of glomerular lesions. Glomerular injury mediated by 
neutrophil involves the local release of glomerular basement membrane 
degrading proteases or glomerular basement membrane halogenations which is 
induced by the interaction of neutrophil-derived myeloperoxidase with 
hydrogen peroxide and a halide. Glomerular injury thus induced by neutrophil 
is augmented further by platelets. 
Other non-suppurative complications: 
  One of the fatal complications of S.pyogenes is Streptococcal Toxic 
Shock Syndrome.(STSS)  Infection in any part in the human body may lead to 
STSS, but it most commonly occurs in association skin infection. It is 
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characterized by toxic signs and a rapidly progressive clinical course and is 
associated with a very high mortality rate exceeding 50%.  
Psoriasis is one of the most common skin lesions found in adults and is 
distributed worldwide. It is characterized by chronic, well defined, 
erythematous, dry, plaques of different sizes, covered by silvery white, 
imbricated and lamellar scales, with corresponding histological skin changes. It 
is associated with considerable impairment in the quality of life of the affected 
patients. The prevalence of psoriasis differs in different populations ranging 
from 0.1% -11.85% in accordance to the published reports
10
. The etiology and 
pathogenesis of the disease is still very unclear but the evidence from various 
studies suggests that it is caused by the interaction of one or more genetic 
components & environmental factors including β-hemolytic streptococci. 
S. pyogenes can also exist in the female genital tract. Bacterial vaginosis 
is caused by various organisms, and S.pyogenes was not previously considered 
as one of the causes of this bacterial vaginal infection.
11
 In last two decades the 
incidence of S.pyogenes vaginosis has increased. 
Studies regarding this increased prevalence suggest that the persons who 
carry S. pyogenes in their respiratory tract either as normal commensal or as a 
pharyngeal infection introduce the pathogen into the female genital tract.  
Owing to the increase in the incidence of infection, most of the 
laboratories are making changes in the protocols related to the detection and 
16 
 
isolation of S. pyogenes. Many laboratories have now included S. pyogenes in 
their protocols as a potentially dangerous vaginal pathogen that, must be 
identiﬁed, in addition to other bacterial pathogens, when present.9 
The recognition of targeted dysfunction of the basal ganglia has led to 
the hypothesis that Sydenham’s chorea and other central nervous system 
illnesses have a post-streptococcal autoimmune etiology. Pediatric autoimmune 
disorders associated with Obsessive compulsive disorder or Tic disorders also 
appear to occur in association with Group A streptococcal infections. In 
addition, the post infectious complications of streptococcal infection also 
include dystonia, dystonic choreoathetosis and chorea encephalopathy as 
documented in various studies. Various antistreptococcal-antineuronal 
antibodies and also genetic markers in patients who are susceptible to these 
illnesses have been described and isolated by many investigators.
12 
 
Virulence factors 
The successful colonization of mucosa of the upper respiratory tract and 
skin forms the initial step in the pathogenesis of group A Streptococcal 
infection.  
The adherence factors include: 
1. Lipoteichoic acid,  
2. M protein and pili,  
17 
 
3. Fibronectin-binding proteins like Sfb1 and Sfb2  
  These are some of the adherence factors for epithelial cells which plays 
major role in the virulence. The fibronectin binding protein will help in the 
endocytotic uptake of the organism into the respiratory epithelial cells. This 
process of invasion into the cell permits the organism to gain access to a 
intracellular niche, and this is the first step in the pathogenesis. 
The potency of Group A Streptococci to resist the normally functioning 
innate clearance mechanism of the host for preventing microbial dissemination 
is defined by the ability of the organism to cause serious infections in otherwise 
healthy adults and children 
13-15
. For instance, when the pathogen invades the 
deeper tissues through a break in epithelial integrity or through cellular 
invasion, specific peptidases are produced which inactivate the neutrophils. 
Similarly, it also secretes cysteine protease, which along with the streptococcal 
pyrogenic exotoxin (Spe) B, can lead to degradation of the antibodies produced 
by the host.
16
  
Streptolysin S (SLS) and Streptolysin O (SLO) are the pore-forming 
toxins secreted by S.pyogenes are lethal to macrophages and neutrophils 
present in the host and thus help in promoting tissue damage and resistance to 
phagocytic clearance. The accelerated apoptosis of immune cells is induced by 
Streptolysin O.
16
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The hyaluronic acid capsule of GAS prevents the phagocytic recognition 
by simulating a common human matrix and thus blocking the opsonin targets. 
Under the influence of innate immunity inside our body the highly invasive 
form of M1T1 GAS strain, develop mutation in the covR/s gene which increase 
the capsular component and other virulence factors
 
 phage mediated virulence 
factor DNAse Sda1 protects the GAS from neutrophil mediated killing. Serum 
inhibitor of complement (SIC) mainly acts by inactivating the complements. 
There are more than 15 types of bacterial super antigens that are grouped under 
SPE family, among which SPE A and C are encoded by bacteriophage
17
. 
These super antigens causes enhanced activation of T lymphocytes, 
inhibit antibody synthesis, induce endotoxic shock, fever and also the release of 
pro inflammatory cytokines. It can lead to multi organ dysfunction, which is 
characteristic of STSS. SpeA producing strains have no antibodies to both M 
protein and super antigens but they have specific human leucocyte antigen. 
These strains are commonly associated with STSS in US. spe A and C  in 
scarlet fever induce specific antitoxin antibodies which prevents the recurrence 
of rash in scarlet fever but doesn’t prevent the recurrence of GAS  infection.18  
S. pyogenes penetrate the host tissues by various virulence factors.  
The hyaluronic acid capsule prevents the bacteria from the attack of 
neutrophils. M protein, lipoteichoic acid and protein F helps in the attachment 
of bacterium to the host cell. Among these the M protein helps the bacteria to 
escape from the alternate complement pathway and some serotypes capable of 
19 
 
binding to the fibrinogen and thus preventing opsonization. Our immune 
system mainly target against these M proteins which are unique to bacteria.
5 
 
M protein 
The M proteins were discovered by Lancefield and constitute the 
structural basis for typing of GAS. They are fibrillar proteins projecting about 
60 nm out from the streptococcal cell wall with a molecular weight of 35, 000 
KDa. Two alpha-helical proteins form a so-called coil-coiled structure which 
was quite similar to the alpha-helical coiled-coil structure in host tissue 
proteins like tropomyosin and the keratin-desmin-vimentin and keratin-
myosinepidermin-fibrinogen-families of molecule. Functionally, the M-protein 
inhibits phagocytosis, which is a primary virulence mechanism for survival in 
tissues. 
 
20 
 
The major function of M protein is tissue invasion & adhesion mainly in 
respiratory and skin tissues, this M protein plays role in tissue tropism based on 
serotypes. This M protein has variable n-terminal region which plays major 
role in the resistance of phagocytosis. In addition this M protein has property of 
binding to the human immune system by non overlapping site. 
The complement inhibitor C4b-binding protein and IgA-Fc.
19 
are the two 
main factors to which the M protein gets attached. emm gene codes the M 
protein as far now more than 150 emm types have been identified.  Extensive 
study about this emm gene has major role in Group A Streptococcal vaccine 
development. PrtF1 and PrtF2 are the fibronectin proteins which also take part 
in the tissue adhesion and intracellular invasion by S.pyogenes
20-22  
The GAS genome
  
The size of the GAS gene is 1.9mb roughly, it has single chromosome 
which is circular in nature. 10 M types have been sequenced so far, the size of 
the genome varies between 1.815, 783-1.937. it has the base pair size of 112 bp 
and it varies with strains. 
Pathogenesis of GAS infections:  
 GAS causes serious infections in humans by 3 main mechanisms like: 
i. Suppuration, which is found in pyoderma and pharyngitis 
21 
 
ii. Elaboration of the toxin, which is the case in Staphylococcal 
toxic shock syndrome (STSS) and  
iii. Immune mediated inflammation, which happens in PSAGN and 
Acute rheumatic fever 
23
 
Rheumatic fever (RF) is a condition where it affects arterioles around 
the connective tissues, and also untreated streptococcal throat infection can act 
as a predisposing factor.  The mechanism of causing infection is supposed to be 
due to   cross reactivity within antibodies. This basically is a reaction of class 
two hypersensitivity and hence it is known as   molecular mimicry. Often, self 
reactive B cells can be anergic in the circulating periphery without   a co-
stimulation from the T cells. In case of infection, antigen-presenting cells 
(APC) which are mature like B cells can present antigen of the bacteria to 
CD4+ T cells which eventually differentiate into T2 Helper cells. These cells 
further activate these B cells to transform into   plasma cells and promote 
antibody   production   against the streptococcal cell wall. However, antibodies 
can react even against the joints and myocardium thereby, producing symptoms 
and signs of rheumatic fever. 
  The cell wall of Streptococcus pyogenes is made of polymers which are 
branched which can contain protein M which are very much antigenic. The 
immune system generates antibodies against the protein M which may cross 
react with the muscle cell protein of the heart called myosin, glycogen of the 
22 
 
smooth muscles of arteries and heart  muscle, thereby inducing release of 
cytokine and destruction of  tissues. The only cross reaction proven is that with 
the peri vascular connective tissue. This reaction occurs by directly attaching 
the complement and receptor Fc mediated recruitment of macrophages and 
neutrophils.  
  Aschoff bodies are characteristic, containing swollen eosinophilic 
collagen which is swollen and surrounded by macrophages and lymphocyte 
which is visible on light microscopy.  Anitschkow or Aschoff giant cells are the 
transformed macrophages which are larger in size. Cell-mediated immunity is 
involved in rheumatic valvular lesions reaction as these contain macrophages 
and helper T cells.  
The above said lesions can be found in any layer of the heart in 
rheumatic fever thereby causing carditis of different types.  It can cause a 
pericardial exudate which is sero fibrinous known as ‘bread and butter’ 
pericarditis, and it usually resolves without any particular sequelae. Involving 
the endocardium results in the formation of a verrucae and fibrinoid necrosis 
along with the lines of closure of left sided heart valves.  Projections which are 
warty can arise from the deposition, whereas lesions in the sub endocardium 
may induce thickening which are irregular, and known as MacCallum plaques. 
Acute glomerulonephritis (AGN) consists of a particular set of renal 
diseases which are immunologic and inflammation is triggered and the 
23 
 
glomerular tissue gets proliferated which results in damaging the basement 
membrane, capillary endothelium or mesangium.  Acute nephritic syndrome is 
the devastating form among the various renal syndromes.
23
 
Antigenic sharing of Group A Streptococci 
A study conducted in Japan about the antigenic sharing of S.pyogenes 
with Streptococcus mutans showed that there was a polysaccharide antigen 
shared by these two Streptococcus species. In this study they have used animals 
to investigate the antigenic property by using mono clonal antibody f-77 which 
reacts with the polysaccharide antigen. This antigen was isolated from patients 
with post glomerulonephritis. 
Immunological response 
Group A Streptococci has many antigenic components and that gives 
type specific protective immunity. The antibodies produced against this M 
protein will stay upto many years and give immunity against severe infections 
caused by GAS but not give any protection against pharyngeal carriers
24
 the 
specific feature of these immunoglobulins are transplacental transmission.  
The antibodies against M protein will appear one month after the initial 
infection, hence these antibodies will help in the prevention of re infection by 
the same serotype of S.pyogenes. Antistreptolysin O antibodies which are 
produced by host humoral immune system can be identified by neutralization 
test. This will be useful in the epidemiological study about the GAS infections. 
24 
 
 Estimation of ASO titre is one of the useful test for identifying the 
streptococcal antibody but the sensitivity of the test is low since these ASO 
produced by both Group A and Group A Streptococci. The ASO titre will be 
high in children than in adult normally.  
Characterization of strains and its classification 
S.pyogenes has many surface proteins which are responsible for its 
virulence. There are three surface proteins namely protein T, protein M and 
serum opacity factor protein. Serogrouping of S.pyogenes is mainly based on 
these proteins.  
As for now 25 serotypes have been identified based on agglutination in 
T protein. In M protein, based on hyper variability of N terminal it is classified 
into 80 serotypes. PCR method also plays a role in the serogrouping of M 
protein by using different probes. 
Genotyping of the S.pyogenes based on emm gene (180bp) is the gold 
standard test currently. The original serologic M types were up to M 81, and 
the new types of emm  from 82-124 are validated and  accordingly added 
7
. 
Currently over a hundred emm types have been sequenced and higher numbers 
are being identified and stored at CDC. Pulsed field gel electrophoresis where 
they target the whole bacterial genome and it is the typing method which is 
being used widely. 
25 
 
Epidemiology of S.pyogenes infection: 
 S. pyogenes is widely present all over the world. A study conducted by 
US showed that, over ten million cases of throat infections are documented 
annually.  Of all the reported cases, only 5 to 10% was caused by streptococcal 
throat isolates, with Beta Hemolytic Streptococci being the most common 
agent.  
It is estimated that around five to fifteen percent of normal individuals 
carry the bacteria which are known to cause sore throat called as colonisation. 
The mortality and morbidity rate of sore throat caused by Streptococcus is 
minimal. The mortality and morbidity rates arising from the complications of 
streptococcal throat infections are increasing. Data from CDC reports every 
year has reported an occurrence of 500 to 1000 cases of necrotizing fasciitis 
and 2000 to 3000 cases of STSS caused by GAS. Throat infections caused by 
Streptococcus may spread by direct or airborne contact with droplets like saliva 
or nasal discharge from any person infected with Streptococcus pyogenes. 
Some isolated reports of infection through contaminated food and indirect 
contact by handling objects of the person infected. 
Streptococcus pyogenes will enter through the abraded skin open sores 
or through the oral cavity and reaches the blood for its nutrients. Children are 
prone to GAS infection than any other population as they are less caring at 
protecting themselves or the others from spreading of the infections. This is 
26 
 
more when children are in close contacts such as schools and daycares.  The 
higher infection rates occur between the months of October to April. Since the 
easy availability of the antibiotics the prevalence rate of GAS infections mainly 
rheumatic fever has declined
7
.
 
 
Age and sex specific rates of infection: 
A study about the prevalence of GAS pharyngitis reported that 
approximately 616 million of Group A Streptococcal pharyngitis occurs per 
year globally. In developing countries like India the epidemiology of GAS 
infections are not documented properly.  
Asymptomatic carrier of GAS pharyngitis which is common among 
children is distributed variedly from one country to other in the range of 9% to 
34.1%. But in India the prevalence is around 4.2% to 13.7% which is as similar 
to the rates as reported from developed countries (USA)
25
. Similarly the 
prevalence in various parts of India varies from 11.2% to 34%. Around 0.3% in 
endemic and 3% in epidemic resulted in acute rheumatic fever and among these 
60% developed RHD (rheumatic heart disease) by the damaged heart valves. 
Even though we could see a declining pattern of ARF/RHD in various parts of 
the world, it still continues to be a major cause of cardiovascular mortality and 
morbidity in India. The spread of GAS infection is common in crowded and 
closed areas. The gold standard diagnosis is throat culture. It takes around 2 to 
5 days to enter and cause the first symptom in case of streptococcal pharyngitis. 
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In south India the research on Group A streptococcal infections are very 
cumbersome and it is mainly a hospital based study. As per these studies the 
prevalence of these streptococcal infections are common among low socio 
economic status children who are less than 15 years 
26,27
. 
When compared with general population below 5 years Children and 
above 65 years have the higher incidence of GAS infections. A study 
conducted in Sweden showed the incidence rate of GAS infections in children 
was 2 or less per 100,000 populations. This is lower than the developed 
countries like USA, Canada. The incidence of GAS infections showed a slight 
male dominance in some countries.
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Mortality associated with invasive infections 
Persons those who stay in long term care facilities are more prone to get 
GAS infection than others. These persons show high case fatality rate than 
general populations. Every year approximately 163,000 deaths reported due to 
GAS infections as per WHO estimation; this may be low because of the 
unavailability of data from many developing countries. 
Estimation of case fatality rate is based on many factors like death 
within seven days of infection and other measures.
29
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Trends in emm type prevalence: 
emm gene codes the M protein , which is responsible for most of the 
GAS infections. There are many types in emm gene but most prevalent types 
are emm type 1, 3, 12, 28 and 89.  Approximately 50% of the isolates belong to 
any one of these five types 
11 
Factors predisposing to invasive S.pyogenes infections: 
There are many factors involving in the occurrence of GAS infections. 
Mainly age, sex, climate and socio-economic status of the person. Related to 
age, extremes of age is more prone to get infection than adults. Overcrowding 
and contact with the children who have the sore throat will increase the risk. 
Low socio economic status mainly poor hygienic practices may increases the 
chance of getting infections.
30
 
 Immunocompromised patients and persons with debilitating diseases 
like diabetes, cardiac illness and malignancy are the risk factors. The other risk 
factors include alcoholism, IV drug abusers and burns or trauma to the skin. 
Nosocomial spread also occur with GAS infections. Roughly about 17-20% of 
GAS infections occur without any risk factors
31-33 
Seasonal variation:  
The main feature of S.pyogenes infections is seasonal occurrence. The 
frequency of invasive disease caused by S.pyogenes varies depending on 
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season; the frequency is higher between late winter and early spring. Late 
summer/autumn shows lower frequency but few exceptions have been reported 
in Europe.  The invasive disease like scarlet fever and streptococcal pharyngitis 
show the similar seasonal pattern.  The etiology of impetigo is shared between 
Staphylococci & Streptococci and it has the peak in summer and it may be 
related to insect bite. USA and Canada shows the similar seasonal pattern apart 
from Europe and it has been reported in a study from USA. A study about 
Streptococcus suis infection in pigs showed the same seasonal pattern and the 
similar seasonal pattern showed by invasive pneumococcal disease also
34
. The 
reasons behind the seasonal variations are change in environmental conditions, 
effect of climatic changes on our defense mechanism, effect of ultraviolet rays 
on our immune system and also seasonal viral infections add to this.
7
  
Treatment and preventive measures  
Control of S. pyogenes in community settings 
 There are only limited chances to prevent the occurrence of S.pyogenes 
infections Varicella infections are the important risk factors among children 
and so preventing such infections could lead to reduction in streptococcal 
infections. A study conducted in Canada showed that varicella vaccination if 
administered to children universally it would result in prevention 10% of the 
streptococcus infections. Only certain developed countries have decided to 
administer varicella vaccination in their immunization schedule.
35
 Recurrence 
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of infections occur among drug users and so steps should be taken to detect 
signs of disease among them at the earliest. The management of critical 
situations depends on the timely decisions and the administration of appropriate 
antibiotics. Activities like military camps and sports result in increased chance 
for occurrence of soft tissue infections.  Under these situations they should be 
advised not to share personal things and also about decontamination of shared 
items.
 
The limited data available about the risk among household contacts is 
the reason for limitations in secondary control measures to prevent the 
infections. Collecting such data will provide information of all the involved 
cases in a particular population in that period, risks involved among 
households. But these estimates are prone to have increased margin of error 
since the sensitivity of surveillance system is poor and also there are difficulties 
in obtaining information about household contacts. A study was conducted by 
USA and Canada to find out the household contacts in a particular time period 
in which they have identified only five household clusters and another five 
have been identified in UK. This sample determines that the risk to household 
contacts from less sample size is not significant. The strategies to control the 
household cases vary between different countries which depend on the 
evaluated risk
5, 6
.  
  The antibiotic prophylaxis varies between countries , in USA they give 
antibiotic prophylaxis to household members those who are at risk where as in 
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Canada they recommend prophylaxis to all family members where a GAS 
infection arise in the community. Recommendation of antibiotic prophylaxis 
and community contact management guidelines was first introduced by UK
36
 
S.pyogenes infections are still there in maternity care centre in many 
developing countries, though they provided with adequate hospital hygiene 
guidelines. This results in death of patient occasionally. In case of outbreaks it 
is important to break the transmission cycle by early isolation and identification 
and antimicrobial prophylaxis. In case of varicella outbreak along with 
immunization, antibiotic prophylaxis should be given to prevent secondary 
bacterial infections
36 
Control of S. pyogenes in hospital and institutional settings 
Puerperal infections and post partum mortality will be markedly reduced 
if the hospital infection control strictly follows the effective hand hygiene 
measures and droplet precaution measures. In developed countries like USA, 
Canada, Sweden, they have made specific strategies to control the infection 
caused by S.pyogenes in maternity settings. They advised screening test for the 
staff nurses those who are dealing with affected patients and also to their 
household contacts. In case of outbreak of S.pyogenes infection in a 
institutional settings, it is advised to use antibiotic prophylaxis to break the 
transmission cycle. 
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Infection Control 
 Centre for disease control has published certain standards and 
guidelines to control the infections caused by S.pyogenes. 
Patient-to-Personnel Transmission:  
Strict adherence to the standard precaution will help in prevention of 
hospital acquired infection by S.pyogenes. The persons who deal with the cases 
should wear gown and glove when collecting secretions from the patients and 
while doing wound debridement to avoid contact with the secretions. Hand 
washing is mandatory to avoid the spread of infection from one patient to 
another patient. Once the results obtained the materials like pus, throat swabs, 
blood, wound swab and body fluids should be disposed in a proper manner. 
This will help in the secondary spread of infection to those who handle the 
secretions from the infected person. 
Personnel-to-Patient Transmission 
The carriers who harbor the Group A Streptococci are responsible for an 
outbreak of surgical wound infection in operation theatre. By the same way the 
carriers who work in the delivery room will cause outbreak of postpartum 
infections.  Pharynx, female genital tract and skin are major reservoir of GAS 
carriers. The main mode of transmission of Group A Streptococci is by direct 
contact. The occurrence of wound infection is uncommon by S.pyogenes. 
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Isolation of > 2 cases of Group A Streptococci needs epidemiological 
investigation.   
  Restriction from patient care activities and food handling is indicated for 
personnel with Group A Streptococcal infections until 24 hours after they have 
received proper antibiotic therapy. However, work restrictions are not 
necessary for personnel who are colonized with Group A Streptococci unless 
they have been epidemiologically connected to transmission of infection within 
the facility. The most important means of controlling any Group A 
Streptococcal disease is correct and timing identification and treatment of 
infections. Children with GAS throat infections should not return to the 
preschool or child care centre until at least 24 hours after starting antimicrobial 
therapy and until they become afebrile. Contacts of recorded cases of 
streptococcal infection who have recent or present clinical evidence of GAS 
infection should have appropriate cultures taken and must be treated if the 
culture is positive. 
Antimicrobial resistance 
Due to the development of rapid resistance to various treatments of 
streptococcal infections deciding a appropriate   for invasive streptococcal 
infection is a big challenge. In Nepal a study was conducted and found that 
there is high resistance to Co-trimaxazole about 71.0% which was the 
commonly used drug to treat children with various diseases. The risk of spread 
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of this resistance to other microorganisms is also high. There were no resistant 
strains to Ampicillin and penicillin. During the last seventy years
10 
  Penicillin and its derivatives with stable minimum inhibitory 
concentration remained the treatment of choice for Streptococcal Pharyngitis. 
But nowadays there are reports showing decreased susceptibility to penicillin. 
In Nepal where cuture facilities were not available, like sub health centers 
Penicillin derivatives were commonly used. Though until now there is no 
review reported penicillin resistance to GAS,in developing countries like Nepal 
where they use Penicillin and its derivatives in peripheral health centers also, 
induces the development of resistance  towards this drug also 5.2% of the 
isolates were found resistance to both ciprofloxacin and erythromycin,20 to 
30% were resistant to macrolides. In addition to Penicillin and Ampicillin this 
study found that Azithromycin 100% susceptible drug against GAS.
36-38 
In recent days Azithromycin is the most common prescribed drug for 
respiratory tract infections because of its short duration of infection. But this 
can also development of resistance to azithromycin in future. so it is 
recommended to review the already exiting antimicrobials and their regimen 
before altering the therapeutic regimen. 
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Surgical management: 
 S.pyogenes will cause wound infections and soft tissue infections which 
needs surgical intervention. GAS will produce gangrene and necrosis of the 
affected tissue which should be treated immediately. For necrotized and 
gangrenous tissues, wound debridement along with hyperbaric oxygen should 
be given; this will support the oxygen supply to the necrotic tissues. After 
surgical intervention proper follow up should be advised.   
Treatment 
The main clinical goal in treating GAS infection is based on two factors 
1. Accurate diagnosis at the correct time 
2. Appropriate Antibiotics  
American Academy of Family Physicians says that follow up culture 
should be done if rapid test for S.pyogenes antigen is negative 
Clinician must know about the fatal complication and post infection 
sequlae of S.pyogenes impetigo is the minor infection which may produce 
glomerulonephritis as a post infection sequlae. Hence physician must be aware 
of minor infections caused by Group A Streptococci.  
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Procedures includes in the S.pyogenes infection management: 
Endotracheal intubation, skin aspiration, surgical drainage, lumbar 
puncture and debridement of wound. 
Immediate fluid management should be given in case of shock, central 
or peripheral venous can be used for fluid replacement. Tonsillectomy is 
proven beneficial in children with recurrent pharyngitis. 
Children with varicella infection are more prone to get secondary 
bacterial infection with S.pyogenes, hence aggressive management is 
mandatory in such children. 
Rehabilitation 
 In case of neuropsychiatric manifestations, inpatient care is 
advisable..
40, 41
 physician and neurologist opinion should be obtained. 
supportive therapy is essential in case of neurological defects. 
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Standard treatment of Group A Streptococcal positive pharyngitis for patient’s 
first or second case of GAS pharyngitis in a three month period
40 
ANTIBIOTIC ROUTE REGIMEN DURATION 
Penicillin V 
Give as first choice 
Given in empty 
stomach 
 
Per oral 
Children;20mg/kg/day in 2-
3 divided doses, maximum 
500mg 3 times daily 
Adult :500mg twice daily 
 
10 DAYS 
Erythromycin ethyl 
succinate 
Given if allergy to 
penicillin 
 
Per oral 
 
Children:40mg/kg/day in 2-
4divided doses, maximum 
1g/day 
Adult :400mg twice daily 
 
10 DAYS 
Benzathine 
penicillin G (BPG) 
Give if compliance 
with 10 dayregime 
likely to be a 
problem 
 
Intramuscular 
Children<20kg:600,000U 
once only 
Adult and children> 
20kg:1,200,000 U once 
only 
 
SINGLE 
DOSE 
Amoxicillin  
Useful alternative as 
can be given with 
food improve 
compliance 
 
Per oral 
Weight<30kg:750mg once 
daily 
Weight>30kg:1500mg once 
daily 
 
10 DAYS 
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Guidelines for treatment of recurrence (≥ 3 episodes of GAS pharyngitis in a 
period of three months)
40 
ANTIBIOTIC REGIMEN DURATION 
Oral 
Clindamycin 
Children: 
20-30mg/kg/day in 3 divided doses 
Adult : 600mg twice daily 
 
 
10 days 
Oral 
Amoxicillin;clavulanic 
acid 
Adult : 500mg twice daily 
 
10days 
Parenteral with or 
without oral 
Benzathine penicillin G 
IM dose 1 dose 
Parenteral with or 
without oral 
Benzathine penicillin G 
with Rifampicin 
 
IM dose 
 
4 days 
 
The reason for treatment failure with penicillin in GAS tonsillo 
pharyngitis include  any recent exposure, carrier state, lack of compliance, in 
vivo bacterial co aggregation, in vivo co pathogenicity of β-lactamase 
producing normal pharyngeal flora, , poor antibiotic penetration into tonsillo 
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pharyngeal tissue, early initiation of antibiotic therapy which eventually leads 
to suppression of host immune response which was adequate, intracellular 
localization of GAS, development of tolerance to penicillin or orthodontic 
appliances.
45 
 There is very little evidence to support the above mentioned 
explanations for the treatment failure in GAS tonsillo pharyngitis, and the 
already reported studies are mostly observational or laboratory based without 
any clinical confirmation.
46 
 In Korea, Taiwan Italy the increased resistance of macrolides has been 
documented. In United States the resistance of macrolides drug has been 
documented as 3% - 9%.  
PUBLIC HEALTH MANAGEMENT   
 Treatment of cases 
Group A Streptococcal infections have rapid progression and it has been 
studied that it has high mortality, hence the isolation and identification should 
be done at the earliest for better prognosis.  S.pyogenes responds well to 
penicillin and it is more effective drug . The combination of Clindamycin with 
penicillin is most effective in case of most severe GAS infections and those 
who do not respond to penicillin alone.Certain wound infection caused by 
S.pyogenes needs wound debridement and exploration. In case of multi organ 
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failure the patient should be supported with intravenous fluids and appropriate 
antibiotics along with this, supportive measures should be given
2,3
. 
 Contacts:   
When compared with general population, the persons those who are in 
close contact with invasive GAS infections are more prone to develop GAS 
infections. The screening and antibiotic prophylaxis for contacts is not 
recommended unless they have underlying illness and culture positives. The 
contacts with culture positive should be treated. Persons those who have 
household patients with toxic shock syndrome are more risk of developing 
invasive GAS infections. But this risk is not sufficient to advice for screening 
test and antibiotic prophylaxis. Since the mortality rate among the older age 
group and immune compromised patients are high, these are the people 
targeted for chemoprophylaxis. In children the risk of getting these invasive 
infections are less hence they are not recommended for chemo prophylaxis.   
Development of a group A streptococcal vaccine 
Factors which are associated with mortality helps in prevention of 
diseases caused by S.pyogenes emm types 1,3 & 12 should be included in the 
development of vaccine to prevent the Group A Streptococcal infections. 
Group A Streptococcal vaccine should be targeted to the people those who are 
in long term care facilities. The mortality rate is high in case of elderly and 
certain invasive GAS infections, so these are the target group for vaccination. 
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Vaccines are licensed for use in elderly since it has been proved effective only 
in this age group
6,7 
There are wide number of strategies currently available for preventing 
morbidity and mortality due to invasive GAS infection. But they are restricted 
to promotion of routine infection control and healthy practices and prevention 
of secondary cases in post surgical patients and postpartum patients. A study 
done in US has proved that the proposed 26-valent GAS vaccine prevents 40% 
to 50% of cases associated with invasive GAS infections among children and 
50-60%of deaths among elderly persons. The infection could be successfully 
prevented by vaccination because of the stability of the distribution of emm 
types for prolonged period.  
Invasive Group A Streptococcal infection contributes to the significant 
mortality in the United states.  But compare to the total burden of GAS 
infections the invasive infections are in less proportion only. Development of 
Group A streptococcal vaccine depends on the non-invasive cases like 
pharyngitis in children in industrialized countries. The 26-valent Group A 
Streptococcal vaccine gives protection against pharyngitis in children and may 
give to rheumatic fever which is one of the non suppurative complication of 
Group A Streptococci.
48
  
The distribution of emm and clonal types for GAS infection vary from 
developing countries from USA
49, 50 
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  Multivalent conjugate vaccines are eliminated because of the newer 
technology in the development of protein based vaccine. On the other hand the 
changes in the emm distribution, disease burden in the community should be 
monitored and the population who are at risk should be identified for 
vaccination. This data will help in the vaccine cost-benefit analysis. Certain 
international standards are mandatory to monitor the disease burden in many 
countries. It will help to design the vaccines which will have global utility. 
 S.pyogenes has the surface protein which is variable in nature. The main 
aim of vaccine research is the variable surface M-protein.the vaccine against 
the variable surface M protein gives strong protective immune response. The 
variable nature of M protein at the amino acid terminus is a big challenge in 
vaccine development. A study conducted in Isrel about the prevalence of emm 
type showed 26 valent vaccine gives 60% protection against GAS infections 
cases. Others have developed hexavalent M-protein-based vaccines, and a 
vaccine using the more conserved C-terminus.
5,6
  the surface M protein will 
produce strong immunity in rheumatic fever  and  the antigenecity also highly 
variable, these two are the major reason for the withdraw of the  M protein 
based vaccines.. 
 There is one more vaccine available for prevention of GAS infection 
which is based on C5a peptidase. This protein is shared between S.pyogenes 
and S.agalactiae , hence this vaccine gives protection against both of these 
organism.
7 
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The Group A Streptococci gets colonized in the throat or skin by using 
surface pilus. Pilin is the subunit of pilus which is protein in nature. The T 
typing is based on the pilus and it plays major role in vaccine production. 
6,7 
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Aim and Objectives 
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Aim: 
 To find the epidemiology of Group A Streptococcal infections in and 
around Coimbatore and to study the prevalence of throat carriage of S.pyogenes 
among school children 
Objectives: 
Primary: To estimate the incidence of Group A Streptococcal infections in 
patients and study the prevalence of asymptomatic carriage among school 
children 
Secondary: 
 Isolation of Group A streptococcal infections from throat swabs of 
outpatients and inpatients attending PSG Hospitals 
 Characterization of the isolates by conventional biochemical tests 
 Confirmation of serogrouping by manual and commercial antigen 
extraction methods 
 Comparative evaluation of the above two methods 
 Detection of asymptomatic throat carriage of Streptococcus pyogenes 
among school children 
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 Detection of emm gene among a representative sample of isolates 
obtained. 
 Sequencing and BLAST analysis for identification of subtypes. 
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Materials and Methods 
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TYPE OF STUDY:  
 Prospective observational study 
STUDY POPULATION:  
 Outpatients and Inpatients attending PSG Hospitals and school children 
(in and around) for asymptomatic throat carriage of S.pyogenes 
STUDY LOCALE:   
PSG Hospitals  
SAMPLE SIZE:  
638 (495 school children and 143 isolates from patients)  
SAMPLE SIZE ESTIMATION:  
n=4pq/d
2
 
n = required sample size  
 p=expected prevalence 
q=100-p 
d= degree of prevalence 
n=638 
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SAMPLING METHOD:  
Convenience method for patient isolates and school children aged 5-15 
years 
INCLUSION CRITERIA:  
Outpatients and Inpatients with suspected cases of acute pharyngitis and 
rheumatic fever, cellulitis, impetigo ,erysipelas, necrotizing fasciitis , 
mastoiditis, tonsillitis, otitis, pneumonia and bone and joint infections.  
Healthy school children aged 5-15 years. 
EXCLUSION CRITERIA:  
Children who were on antibiotics for suspected throat infections. 
CONFIDENTIALITY:  
Confidentiality of the reports was maintained. 
ETHICAL CLEARANCE:  
The Institutional Human Ethical clearance was obtained before the 
commencement of the study. Informed consent was obtained before the 
collection of throat swabs from parents of the school children (Assent form) 
A questionnaire was designed and the details obtained were filled. 
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ALGORITHM FOR IDENTIFICATION OF GROUP A STREPTOCOCCCI 
 
    Throat swab, wound swab, pus,                   Throat swabs from school children 
      blood (IP and OP)   (n=143)                  (Asymptomatic and healthy) (n=495) 
    
                                             
Blood agar and Mac Conkey agar 
  
Beta hemolytic colonies 
 
              
Bacitracin sensitivity                PYR                      Ribose fermentation 
  
 
 Streptococcus pyogenes 
  
                                                                      Serogrouping 
 
         Using manual acid extraction method         using commercial Latex kits 
 
 
Representative sample of 50 isolates 
 
Molecular typing for emm gene by PCR 
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THROAT SWABS:   
 Sterile swabs were taken and swabs were collected from the throat from 
school children. The same was streaked on sheep blood agar and were kept at 
37
0
C in candle jar for 24 hours.  
1. Growth on sheep blood agar:  Following overnight incubation of the 
sample, colonies of Streptococcus seen as grey colonies of about 0.5 -
1mm in diameter with beta (complete) hemolysis were taken as 
presumptive streptococcal colonies. 
2. Catalase test: A drop of catalase reagent (3% hydrogen peroxide) was 
added to the slide. The growth was further applied to it with an 
applicator stick. Appearance of bubbles was taken as positive. 
Streptococcus colonies showed no bubbles which was taken as negative. 
3. Gram stain: Smears made from colony showed Gram positive cocci in 
chains. 
STORAGE:  
 If the isolate was catalase negative, gram stain showing the presence of 
gram positive cocci in chains and growth in blood agar showing beta hemolytic 
colonies, they were sub cultured and pure growth was stocked in Robertson’s 
cooked meat medium in tubes. The tubes were sealed and stored at 4-8
0
C and 
when further tests were to be done they were further sub cultured. 
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Storage by Lyophilization: 
For long term storage the streptococcal isolates were stored by 
lyophilization method. 
Two to three colonies of beta hemolytic streptococci was taken and lawn 
culture was made on blood agar and kept at 37
0
C for 24 hours. The vials were 
autoclaved and kept. Brain heart infusion broth and milk broth were prepared 
for the storage of the isolates. The colonies from the lawn culture in blood agar 
was scrapped and mixed well in the vial which contain 0.5ml of milk broth and 
0.5ml of brain heart infusion broth. The vials were kept at -20
0
C for 48 hours 
and lyophilization done.  
IDENTIFICATION TESTS: 
1) Bacitracin sensitivity: A well isolated colony of Streptococcus from the 
culture was taken and lawn culture was made on blood agar plate. Then 
0.04-0.05 international units of Bacitracin disc was kept over the lawn 
culture. Following overnight incubation at 37
0
C the zone of clearance 
was measured. Zone of inhibition by greater than 14mm was taken as 
sensitive for Streptococcus pyogenes. 
2) PYR test: The colonies were inoculated in PYR broth and incubated for 
a period of 4 hours. Later 3 drops of PYR reagent was added to it and 
change of colour to red was confirmed positive indicating Streptococcus 
pyogenes where as absence of colour change indicates negative test. 
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3) Ribose fermentation: Species identification was further done by sugar 
utilization by inoculating the organism in peptone with 1%sugar with 
Andrade indicator. Any change in colour from colorless to pink 
indicated the positive sugar fermentation test. Absence of colour change 
was taken as negative. The ribose was not fermented in Streptococcus 
pyogenes. 
4) Serogrouping: Serogrouping was done by two methods.  
  
a) Manual acid extraction method: 
Micro nitrous acid extraction method: 
1) 20 micro litres of 2% sodium nitrite solution was taken in a test tube. 
2) 3 to 4 colonies of beta hemolytic streptococci were added to the test 
tube. 
3) Glacial acetic acid (3microlitres) was added to the suspension and kept it 
at room temperature for 15 minutes. 
4) 16 to 24 micrograms of sodium bicarbonate was added for 
neutralization. 
5) Finally 60microlitres of distilled water was added.  
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Agglutination method: 
1) One drop of micro nitrous acid extract was added to the circle on the 
slide by using Pasteur pipette. 
2) To this one drop of latex reagent was added to each circle. 
3) The slide was mixed by rotation for about 1 minute. 
4) Evidence of agglutination against diffuse light was considered as 
positive. 
5) The group reagent which gave the strongest agglutination denoted the 
group of the streptococcal isolate. 
b)  Commercial Latex kits method: 
Principle: 
Streptococci have group specific antigens in their cell walls which is 
carbohydrate in nature. After extraction by a specially prepared enzymatic 
method these antigens will react with latex particles coated with the 
corresponding antibody and produces agglutination. The latex remains in 
smooth suspension if there are no of group specific antigens. 
Name of the kit: STREP TEST KIT- PLASMATEC 
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Kit presentation 
1. Latex determination for the grouping of streptococci A, B, C, D, F, G.  
2. Polyvalent positive control 2ml 
3. Freeze dried extraction Enzyme. Two vials, reconstituted each with 
10ml of distilled H2O. 
4. Disposable test cards 50 in number. 
5. Mixing sticks 300 and kit insert. 
Method: 
1) By using sterile bacteriological loop 2-6 colonies of streptococci was 
taken and emulsified in 0.4ml of extraction enzyme. 
2) The tube which contains the bacterial colonies with extraction enzyme 
was kept for10 minutes at water bath 56
0
C , the tube was shaken 
vigorously after 5 minutes of incubation. 
3) The latex reagent was re-suspended by gentle agitation; one drop of 
latex reagent was added to each circle on the test slide. 
4) One drop of the extract was added to each drop of latex reagent by using 
Pasteur pipette and the content was mixed well by using separate mixing 
stick. 
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5) The slide was rocked for not more than one minute, and the 
agglutination was observed 
6) Visible agglutination of the latex particle was noted in the circle which 
marked as A which indicates positive result. 
MOLECULAR STUDY OF ISOLATES: 
The isolates of Group A streptococci were streaked on blood agar plate 
and incubated for 24 hours at 37
0
C.The pure colonies were taken and 
inoculated into 10ml of Brain Heart infusion broth in sterile tarson tubes and 
then incubated for 24 hours at 37
0
C. 
After 24 hours those tubes were centrifuged for 5 minutes and the 
supernatant fluid was discarded the pellets were transferred onto two ml sterile 
capped tube for DNA extraction. 
 DNA EXTRACTION:  
The DNA from Group A Streptococci was extracted by Bacterial 
Genomic DNA Purification Kit. 
Kit: HIPURA Bacterial Genomic DNA Purification Kit 
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DNA EXTRACTION PROCEDURE: 
1) Lysozyme solution was prepared by using lysozyme from chicken egg 
white, which is provided in the kit. 
2) 1.5 ml of bacterial broth culture was taken in the 2ml capped collection 
tube by centrifugation for 2 minutes at 13000 rpm. The culture medium 
was removed completely and discarded. 
3) The pellet was re suspended in 200microlittre of lysozyme solution and 
incubated for 30 minutes at 37
0
 C. 
4) 20 microlittre of Proteinase K was added to the sample. 
5) 200 microlittre of lysis solution was added, vortex done thoroughly for 
few seconds and incubated at 55
0
C for 10 minutes. 
6) 200 microlittre of ethanol was added to the lysates prepared already.  
7) The lysate obtained was transferred into HiElute Miniprep Spin Column 
(capped) and centrifuged at 10000 rpm for 1 minute. The flow through 
liquid was discarded and the spin column was placed in the same 2ml 
collection tube. 
8) Prewash: 500microlittre of prewash solution was added to the column 
and centrifuged at 10 thousand rpm for 1 minute. Flow through liquid 
was discarded and the same collection tube re-used with the column. 
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9) Wash: 500microlittre wash solution was added to the column and 
centrifuged for 3 minutes at a maximum speed 13,000 rpm. Flow 
through liquid was discarded and centrifuged again at same speed for 
additional 1 minute to dry the column. 
10) The HiEilute Miniprep Spin column was transferred into fresh uncapped 
collection tube.200microlittre of elution buffer was added into the 
column without spilling to the sides of the tube and incubated for 1 
minute at room temperature then centrifuged at 10 thousand rpm for one 
minute to elute the DNA. The elute was transferred into a fresh capped 
2ml collection tube for longer storage at -20
0
C.   
DNA Amplification 
The extracted DNA from the isolates were amplified by using Real time 
PCR-AB Applied biosystems. 
Sterile 1.5ml tubes were taken for the preparation of PCR 
Master mix- 12.5microlitres 
PCR water- 8.5microlitres 
DNA lysate- 2micrlittre 
Forward primer- 1microlitre (Primer F 5’TATTCGCTTAGAAAATTAA3’) 
Reverse primer- 1microlitre (Primer R 5’GCAAGTTCTTCAGCTTGTTT3’) 
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The temperature setup was done for the following steps 
Holding time- 95
0
C for 5 minutes 
Denaturation- 95
0
C for 30 seconds 
Annealing - 46
0
C for 45 seconds 
Elongation – 720C for 59 minutes 
Final elongation- 72
0
C for 7 minutes 
At the end of 30 cycles the amplified products were obtained. 
GEL ELECTROPHORESIS 
1. Sterile beaker was taken, 1x buffer was prepared, and 80 ml of 1 x 
buffer was added with 0.76 grams of agarose powder and then kept in 
the micro wave oven for melting for 3 minutes. 
2. After 3 minutes the agarose was cooled to 400C, to this 2 microlittre of  
Ethidium bromide was added 
3. In 80ml trough the agarose gel was poured with 15 numbered comb to 
make wells. After the agar gets solidified the comb was taken out slowly 
4. In the first well the 100 base pair ladder was added to the rest of the 
wells the amplified DNAs were added. 
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5. 5 .The gel was run at 95 volts for 45 minutes and the appearance of 
bands were noted under UV light. 
6. The bands at 912 base pairs indicates emm gene. 
7. The subtypes of emm gene were analysed by EuroFins Genomics 
(Bangalore) and the results obtained were subjected to BLAST analysis. 
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Results 
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A total of 638 samples were collected and processed from school 
children and PSG Hospitals during the study period January 2015 to July 2016. 
Out of 638 samples 495 collected from school children and 143 samples 
collected from patients samples from PSG Hospitals. 
Among 495 throat swabs collected from school children 7 children 
(1.4%) are carriers of Group A Streptococci. 5 children (1.0%) are carriers of 
Group G Streptococci.  
Among 143 samples collected from PSG Hospitals 67 (46%) were found 
to be Group A Streptococci and 76 (53%) were found to be other serogroups of 
beta hemolytic streptococci. 
Figure 1 shows the distribution of Group A and Group G Streptococci 
among the total samples collected from school children. 
Figure 2 shows the distribution of Group A Streptococci among 
samples received in Microbiology laboratory. 
Distribution of Group A Streptococci among varies samples received in 
Microbiology laboratory like pus 16 (21%), wound swabs 31 (40%), throat 
swabs 17(22%), blood 11(14%), ascitic fluid 1(2%), pigtail fluid 1 (1%) is 
depicted in Figure 3. 
 Representative samples of 50 isolates were tested for emm gene which 
is responsible for rheumatic fever and molecular study was done for those 50 
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isolates by RT-PCR and Gel electrophoresis method and the bands were 
obtained. 
Figure 4 show bands which indicate the presence of emm gene in the 
positive isolates. 
Figure 5 shows the subtypes of emm gene from the isolates. 
The sequencing pattern of the BLAST analysis is depicted in a graphical 
pattern in Figure 6. 
Table 1 shows the comparison of manual nitrous acid extraction method 
with PLASMATEC commercial strep kit method for sero grouping of 
streptococci for final confirmation. 
Table 2 shows the antibiograms of S.pyogenes collected from various 
clinical samples 
Illustration 1 shows the throat swabs collected from school children 
and sterile sheep blood agar plates used for streaking.  
Illustration 2 shows the appearance of Beta hemolytic Group A 
Streptococci on blood agar 
Gram stain of Streptococcus pyogenes was confirmed as Gram positive 
cocci in chains which is shown in Illustration 3. 
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Illustrations 4 -11 show various biochemical tests done to identify 
S.pyogenes. 
The isolates of streptococci were preserved in Robertson’s cooked meat 
medium and were subcultured periodically. The isolates were also lyophilized 
and stored in the vials. (Illustrations 12 and 13) 
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Illustration 1:  Sterile throat swabs taken from asymptomatic school 
children and sheep blood agar plates for streaking 
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    Illustration 2: Beta hemolysis           Illustration 3: Gram stain of S.pyogenes 
      
  
 
Illustration 4: Catalase test Negative      Illustration 5:  Bacitracin sensitivity 
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Illustration 6:  PYR test positive for Streptococcus pyogenes 
 
Illustration 7:  Ribose fermentation not fermentation negative – S.pyogenes 
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Illustration 8: Manual extraction method for serogrouping of streptococci 
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Illustration 9: Serogrouping by Latex kit method 
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Illustration 10: RTPCR for amplification 
 
Illustration 11:  Gel electrophoresis  
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Figure 4 PCR showing emm gene of band 912 bp 
  
 
Figure 5 PCR showing emm subtypes 
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Illustration 12:  Robertson cooked meat medium for storage of S.pyogenes 
 
Illustration 13: Lyophilization vials – Preservation method for S.pyogenes 
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Table 1: Comparative evaluation of the manual nitrous acid extraction 
and commercial kit for serogrouping of Streptococci 
MANUAL METHOD 
PLASMATEC (Commercial kit) 
POSITIVE NEGATIVE 
POSITIVE 78 
 
0 
NEGATIVE 6 554 
 
Sensitivity =78/84*100 = 92.85% 
Specificity =554/554 =100% 
Positive predictive value =78/78+0 = 100% 
Negative predictive value =554/560 *100 = 98.92% 
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Table 2: Antibiogram of clinical isolates of S.pyogenes 
Total number of isolates, n=77 
                                                             
Name of the antibiotic tested %Sensitive %Resistance 
Penicillin( 10U) 88.32% 11.68% 
Cefotoxime (30µg) 100% 0% 
Vancomycin (30µg) 100% 0% 
Erythromycin (15µg) 64.94% 35.06% 
Clindamycin (2µg) 79.23% 20.77% 
Co-trimoxazole (25µg) 74.03% 25.9% 
Levofloxacin (5µg) 88.32% 11.68% 
                            
 
76 
 
 
  
Figure 6 : Sequencing Pattern of emm Subtypes 
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Discussion 
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Group A Streptococci produce a wide range of diseases from pharyngitis 
to streptococcal toxic shock syndrome.  Since the carriers are more prone to 
spread the infections, they are considered as a major public health problem. To 
avoid post infection sequlae of GAS, it is mandatory to identify the organism at 
the earliest
57-59
 Group A Streptococci mostly colonizes in the throat of an 
asymptomatic carriers. Geographical location and season play a major role in 
the carrier rate of GAS among healthy school children. Several studies reported 
the carrier rates of 15-20% among healthy school children
39 
  In our study the incidence of Group A Streptococci was found to be 0.75 
% among clinical samples in our hospital. This is higher when compared with a 
study conducted in USA which showed 1.5 to 3 cases per 100,000 population
60
. 
One more study conducted in different time period also reveals incidence 
around 3.5 cases per 100,000 population
61-63
. A study was conducted in Canada 
showed the incidence of Group A Streptococci was 1.5 cases per 100,000 
population
64. 
 while another study conducted in Denmark showed the incidence 
of Streptococcus pyogenes infection was 2.6 cases per 100,000 population
65 
The reason for high incidence of Group A Streptococcal infections could 
be middle and low socio economic status, overcrowding , high population 
density, the hot and humid climate , air pollution ,more number of students in 
one class room and poor hygienic practices.
66,67
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Apart from Group A Streptococci the incidence of Group G Streptococci was 
found to be 0.70% among the clinical isolates. This percentage is much less 
when compared to a study conducted in Mumbai which showed the prevalence 
was 22.19%. One more study conducted in New Delhi showed the prevalence 
of Group G Streptococci was 21% 
68
 
A study conducted in school children showed that among  the beta 
hemolytic Streptococci, 40% was contributed by Group A and 60% by other 
groups of Streptococci
75 
Distribution of Group A Streptococci among various samples received 
in Microbiology laboratory which included pus 16 (21%), wound swabs 31 
(40%), throat swabs 17(22%), blood 11(14%), ascitic fluid 1(2%) and pigtail 
fluid 1 (1%). This distribution is more or less similar to a study conducted 
which showed 10.6% of throat cultures, 8.7% of urine cultures, and 7% of pus 
and body fluids.
69
 A study conducted in Germany showed that 53.9% isolates 
were obtained from blood samples and 17.6% isolates were obtained from 
wound swabs.
70 
 
Among the 77 isolates of GAS isolated from various clinical samples, 
11.68% showed resistant to Penicillin, 25% were resistant to Co-trimoxazole, 
11% were resistant to Levofloxacin, 20% were resistant to Clindamycin and 
35% of the isolates were resistant to Erythromycin.  A study about the 
antibiotic resistant in Kolkata showed, S.pyogenes 
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were 100% sensitive to Penicillin, Vancomycin, Cefotaxime, Clindamycin and 
52% were resistant to Tetracycline, 34.7% were resistant to Erythromycin. 
There
 
was an increase in MIC of the Penicillin drug was noted in 5% of the 
isolates 
81. 
 
 
Since the mild throat and skin infections of GAS can lead to fatal life 
threatening complications, rapid and accurate diagnose of the GAS infections is 
important to avoid post infectious immune mediated complications
80 
Comparison of manual nitrous acid extraction method with commercial kit 
(PLASMATEC) for the sero grouping identification of Streptococcus pyogenes 
showed the manual conventional method had a sensitivity of 92% and 
specificity of 100% with positive predictive value of 100%and negative 
predictive value of 98.92%. Similar results have been reported that the 
sensitivity of manual extraction method when compared with commercial Kit 
method was 90% and specificity was 100%
71,72. 
 Similar reports have been 
published the Sensitivity was 97.71% and Specificity was 80.64% for Latex 
agglutination assay. Commercial kits provide as easy and reliable method for 
serogrouping of S.pyogenes.
 
The prevalence of asymptomatic carriers of Group A Streptococci 
among school children screened in our study was found to be 1.4%, this is 
lesser than a study conducted in Guntur, India which showed the prevalence 
was around 12%
29
. This might be explained by the fact that the children are 
from urban areas with middle to higher socioeconomic groups. A study was 
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conducted in North India about the epidemiology of group A streptococcal 
pharyngitis which reported the prevalence of 2.8% which is higher than our 
study
30
 Studies in Karnataka about the prevalence of beta hemolytic 
streptococci in school children between the age group of 5-10 years was
 
30.1% 
which is higher compared to our study. A one year prospective study was 
conducted in Chennai about the prevalence of GAS infection in the age group 
of 5-15years. It was reported that in various parts of the country, the carriers of 
Group A Streptococci was 11.2-34 %
73,74
. Group G Streptococci prevalence 
was found to be 0.25%
 
in few studies
75
 
A prospective study conducted in asymptomatic school children in 
Nepal showed the prevalence of GAS infections was around 10.9%
8. 
While 
another report shows the prevalence Group A Streptococcal infection among 
school children asymptomatic carrier rate to be 0.8%
76
 In our study, apart from 
Group A streptococci some of the asymptomatic school children also were 
carriers of Group G Streptococci which was found to be 1.01%. This correlates 
well with Studies conducted in Turkey where the prevalence of Group G 
Streptococci in pediatric Age group, was of 1% 
77
 
A cluster of emm like gene which includes emm, mrp, enn are located in 
the Vir locus of the GAS chromosome.  The M protein of the GAS encoded by 
emm gene, the hyper variable region of 5’ sequence of emm genes gives 
distinguishable serotypes in M protein. Currently the M protein Serotyping is 
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done by using specific PCR products.   Among the 50 positive isolates of 
Group A Streptococci, 13 emm gene that is 26% identified at 912 base pairs. 
A study about the emm analysis in children with pharyngitis showed 
that, out of 25 GAS isolate sequenced the emm type 3 was present in 80%, 
emm 1 was 16% and emm 79 was 4%. emm 3 was mostly associated with 
severe pharyngitis
78 
compared with this study the incidence of emm gene in our 
study is less. It is of interest that of six emm types more commonly seen in the 
USA (emm 1, emm 3, emm 28, emm 12, emm 4, and emm 11) only emm 12 
was seen in South Indian population. This observation would be of great 
significance in designing a vaccine based on emm sequences, and would imply 
that a vaccine designed for a Western population may not be suitable for India
79 
The BLAST analysis of the representative samples sent for sequencing 
revealed that the subtypes of emm genes identified in our study were 
emm19,113, STP 2736,121,12(RE 611 strain) st 2460, st 6735,401,17 and st 
11014. 
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Summary and Conclusion 
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1. The incidence of Group A Streptococci from various clinical samples 
were found to be 0.75%. 
2. The distribution of Group A Streptococci among various samples were 
pus 16 (21%), wound swabs 31 (40%), throat swabs 17(22%), blood 
11(14%), ascitic fluid 1(2%), pigtail fluid 1 (1%). 
3. 3. The isolates of S.pyogenes were 100% sensitive to Cefotaxime and 
Vancomycin, 88.32% sensitive to Penicillin and Levofloxacin, 79.23% 
sensitive to Clindamycin, 74.03% sensitive to Co-trimoxazole and 
64.94% sensitive to Erythromycin. 
4. The prevalence of asymptomatic carriers of Group A Streptococci was 
found be 1.4% and Group G Streptococci was found to be 1.0% 
5. The prevalence of emm gene was found to be 26% 
6. The prevalence of emm gene was found to be 26% and subtypes 
emm19,113,STP 2736,121,12(RE 611 strain) ,st 2460, st 6735,401,17 
and st 11014 were identified by BLAST analysis. 
7. The commercial streptococcal grouping kit method was found to be 
100% sensitive and specific when compared to conventional method. 
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